As at Jun 22, 2026, the STE stock has a PE ratio of 25.14. This is based on the current EPS of $7.97 and the stock price of $200.4 per share. A decrease of 25% has been seen in the P/E ratio compared to the average of 33.7 of the last 4 quarters.
The mean historical PE ratio of STERIS over the last ten years is 51.12. The current 25.14 PE ratio is 51% below the historical average. Over the past ten years, STE's PE ratio was at its highest in the Jun 2023 quarter at 185.93, with a price of $224.98 and an EPS of $1.21. The Mar 2018 quarter recorded the bottom point at 27.3, with a price of $93.36 and an EPS of $3.42.
Maximum annual increase: 136.57% in 2022
Maximum annual decrease: -67.16% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2026 | 27.75 | -23.6% | $221.13 | $7.97 |
| 2025 | 36.32 | -38.13% | $226.65 | $6.24 |
| 2024 | 58.7 | -67.16% | $224.82 | $3.83 |
| 2023 | 178.77 | 84.85% | $191.28 | $1.07 |
| 2022 | 96.71 | 136.57% | $241.77 | $2.5 |
| 2021 | 40.88 | 40.48% | $190.48 | $4.66 |
| 2020 | 29.1 | -18.4% | $139.97 | $4.81 |
| 2019 | 35.66 | 30.62% | $128.03 | $3.59 |
| 2018 | 27.3 | -49.29% | $93.36 | $3.42 |
| 2017 | 53.84 | 18.98% | $69.46 | $1.29 |
| 2016 | 45.25 | N/A | $71.05 | $1.57 |
| 2015 | N/A | N/A | N/A | $2.27 |
| 2014 | N/A | N/A | N/A | $2.2 |
| 2013 | N/A | N/A | N/A | $79.5 |
| 2012 | N/A | N/A | N/A | $66.77 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 27.75 | -21.19% | $221.13 | $7.97 |
| Dec 2025 | 35.21 | -0.4% | $253.52 | $7.2 |
| Sep 2025 | 35.35 | -3.31% | $247.44 | $7 |
| Jun 2025 | 36.56 | 0.66% | $240.22 | $6.57 |
| Mar 2025 | 36.32 | -16.26% | $226.65 | $6.24 |
| Dec 2024 | 43.37 | -21.32% | $205.56 | $4.74 |
| Sep 2024 | 55.12 | 1.68% | $242.54 | $4.4 |
| Jun 2024 | 54.21 | -7.65% | $219.54 | $4.05 |
| Mar 2024 | 58.7 | 52.47% | $224.82 | $3.83 |
| Dec 2023 | 38.5 | -2.97% | $219.85 | $5.71 |
| Sep 2023 | 39.68 | -78.66% | $219.42 | $5.53 |
| Jun 2023 | 185.93 | 4.01% | $224.98 | $1.21 |
| Mar 2023 | 178.77 | N/A | $191.28 | $1.07 |
| Dec 2022 | N/A | N/A | $184.69 | -$0.28 |
| Sep 2022 | N/A | N/A | $166.28 | -$0.08 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, STE's PE ratio is below the 3, 5 and 10-year averages.
With a P/E of 25.14, STE is above the Healthcare sector average but below the industry and its peers average. But compared to its Healthcare sector average of 24.1, STERIS's P/E is only 4.3% higher.
STE's PE ratio is lower than its peer stocks JNJ and TMO, but it is greater than KMB's and CNMD's. STERIS's current PE ratio of 25.14 is below the average of its peers, which is 26.92.
| Stock name | PE ratio | Market cap |
|---|---|---|
| KMB Kimberly Clark Corp | 16.32 | $34.5B |
| CNMD CONMED Corp | 19.08 | $1.02B |
| STE STERIS plc | 25.5 | $19.84B |
| TMO Thermo Fisher Scientific Inc | 25.75 | $174.35B |
| JNJ Johnson & Johnson | 27.39 | $575.69B |
| MMM 3M Co | 31 | $84.41B |
| SYK Stryker Corp | 35.47 | $118.84B |
| ECL Ecolab Inc | 36.11 | $75.61B |
| ACH Accendra Health Inc. | N/A | $238.18M |
STE's price to earnings ratio is 25.14 as of Jun 22, 2026.
The 3-year average PE ratio for STE stock is 53.89.
The 5-year average PE ratio for STE stock is 66.34.
In the last ten years, the Jun 2023 quarter recorded the highest quarterly PE ratio at 185.93.
STE's current price to earnings ratio is 51% below its 10-year historical average.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jun 22, 2026), STERIS's stock price is $200.4. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $7.97. Therefore, STERIS's P/E ratio for today is 25.14. PE RATIO(25.14) = STOCK PRICE($200.4) / TTM EPS($7.97)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.